Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-016967
Filing Date
2025-06-12
Accepted
2025-06-12 16:35:42
Documents
1
Period of Report
2025-06-11

Document Format Files

Seq Description Document Type Size
1 form4-06122025_080636.html 4  
1 form4-06122025_080636.xml 4 4153
  Complete submission text file 0001415889-25-016967.txt   5568
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Issuer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AKERO THERAPEUTICS, INC. 601 GATEWAY BOULEVARD, SUITE 350 SOUTH SAN FRANCISCO CA 94080
Business Address
Xu Yuan (Reporting) CIK: 0001858214 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40925 | Film No.: 251043379